| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |